Breathe Easy Overview
- Year Founded
-
2009
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Breathe Easy General Information
Description
Developer of therapeutic devices intended to provide better tools for clinicians and patients dealing with Cystic Fibrosis. The company's device liquefies and reduces the viscosity of the thick mucus that blocks the distribution of enzymes in the digestive system and the airflow in the lungs, allowing healthcare professionals to treat Cystic Fibrosis, a genetic condition affecting the lungs and digestive systems.
Contact Information
Website
www.breatheeasytherapeutics.com
Formerly Known As
Cf Newco
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Devices and Supplies
Primary Office
- PO Box 106 818
- Auckland, 1143
- New Zealand
Breathe Easy Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 01-Mar-2021 | 00.000 | Completed | Out of Business | ||
| 7. Seed Round | 01-Aug-2016 | 00000 | 00.000 | Completed | Clinical Trials - Phase 2 | |
| 6. Grant | 01-Jun-2015 | 00000 | 00.000 | Completed | Clinical Trials - Phase 1 | |
| 5. Equity Crowdfunding | 18-May-2015 | 00000 | 00.000 | Completed | Clinical Trials - Phase 1 | |
| 4. Seed Round | 01-May-2015 | 00000 | 00.000 | 00000 | Completed | Clinical Trials - Phase 1 |
| 3. Seed Round | 31-Oct-2014 | 00000 | 00000 | Completed | Clinical Trials - Phase 1 | |
| 2. Seed Round | 01-Sep-2014 | Completed | Startup | |||
| 1. Grant | 01-Oct-2013 | $4.08K | Completed | Startup |
Breathe Easy Patents
Breathe Easy Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2912552-A1 | Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms | Inactive | 23-May-2013 | 000000000 | |
| AU-2014269143-A1 | Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms | Inactive | 23-May-2013 | 000000000 | |
| US-20160120898-A1 | Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms | Inactive | 23-May-2013 | 000000000 | 0 |
| EP-2999464-A1 | Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms | Inactive | 23-May-2013 | 000000000 | |
| EP-2999464-A4 | Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms | Inactive | 23-May-2013 | A61K33/02 | 0 |
Breathe Easy Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Andrea Miller | Co-Founder & Chief Executive Officer | ||
| Gary Pace Ph.D | Executive Chairman |
Breathe Easy Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Gary Pace Ph.D | Self | Executive Chairman | 000 0000 |